EGFR and breast cancer: Over-synthesis of MYOF in breast cancer cell lines leads to an increased invasion phenotype and secretion of matrix metalloproteinases (MMPs), while silencing of the gene restores the normal phenotype, possibly by blocking the EGFR signaling pathway [78,79].